A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumour T cell responses at remission

Derek N. J. Hart, Jennifer L. Hsu, Christian E. Bryant, Michael S. Papadimitrious, Benjamin Kong, Robin E. Gasiorowski, Daniel W. Orellana, Helen M. McGuire, Barbara Fazekas de St Groth, Douglas E. Joshua, Phoebe Joy Ho, Stephen R. Larsen, Harry J. Iland, John Gibson, Georgina J. Clark, Phillip D. Fromm

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)2648
Number of pages1
JournalBlood
Volume130
Issue numberSuppl 1
Publication statusPublished - 7 Dec 2017
Externally publishedYes
Event59th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) 2017 - Atlanta, United States
Duration: 9 Dec 201712 Dec 2017

Cite this

Hart, D. N. J., Hsu, J. L., Bryant, C. E., Papadimitrious, M. S., Kong, B., Gasiorowski, R. E., ... Fromm, P. D. (2017). A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumour T cell responses at remission. Blood, 130(Suppl 1), 2648.